National Drug Strategy
National Drug Strategy

Comorbidity of mental disorders and substance use: a brief guide for the primary care clinician

10.8 Major clinical issues with somatoform disorders and inhalant/ solvent use

prev pageTOC |next page

Table of contents

10.8.1 Effects of inhalants/ solvents on somatoform disorders

10.8.2 Interactions between inhalants/ solvents and therapeutic agents for somatoform disorders

10.8.3 Management approaches to comorbid somatoform disorders and inhalant/ solvent use


prev pageTOC |next page